Enforcement Report - Week of April 17, 2024
Leading generic drug makers Lupin, Glenmark, and Natco Pharma are recalling products in the American market for manufacturing issues, according to the US health regulator.
Enforcement Report - Week of February 7, 2024
Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards
Enforcement Report - Week of June 7, 2023
Enforcement Report - Week of January 25, 2023
Enforcement Report - Week of January 18, 2023
Enforcement Report - Week of October 26, 2022
Enforcement Report - Week of October 5, 2022
Enforcement Report - Week of August 24, 2022